D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income -26.66% -39.38% -31.42% 79.50% -92.64%
Total Depreciation and Amortization -9.09% -6.14% -20.31% -28.67% -38.55%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -18.28% -34.87% -16.61% -96.24% -22.19%
Change in Net Operating Assets -1,421.73% -287.22% 16.02% 425.55% -97.61%
Cash from Operations -120.27% -98.61% -39.00% -46.91% -149.69%
Capital Expenditure 43.48% -176.19% 69.77% -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -339.70% 103.65% -261.36% 111.71% 395.64%
Cash from Investing -340.19% 103.35% -261.79% 111.69% 394.81%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -155.56% 9.09% 51.35% 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 53.37% --
Cash from Financing 2,022.63% 1,111.11% 21,111.27% -103.40% -13,936.36%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 940.41% -91.58% 50.34% 77.05% -100.59%